NEW YORK (GenomeWeb News) — Digilab BioVision today said it will offer GenWay Biotech’s Seppro IgY proteomics technology from its Hannover, Germany, facility.
 
Digilab said Seppro’s IgY technology selectively partitions the 12 most abundant proteins from human serum or plasma.
 
Digilab said its Peptidomics products and services increase the sensitivity and selectivity needed for drug-development proteomics.
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Jul
12
Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.